Remarkably, combination treatment of Meso UCAR T-cells with both FAP(hF1) and FAP(mF3) UCAR T-cells not only restored but further enhanced anti-tumor activity against the HCC70+CAF spheroids significantly, relative to Meso UCAR T-cell activity against HCC70 spheroid alone (Figure 2F). Here, FAP is linked to neoplasm.